Krishnan Suma

President, R&D, Director, 10% OwnerKrystal Biotech, Inc. (KRYS) · full profile →Form 4 · filed Sep 4, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$9.0M
Net Open-Market Flow
-$9.0M
Transactions
13
13 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 4, 2026Sell(S)520$354.54$184K1.3M
Sep 4, 2026Sell(S)2K$355.57$713K1.3M
Sep 4, 2026Sell(S)3K$356.37$1.2M1.3M
Sep 4, 2026Sell(S)4K$357.57$1.4M1.3M
Sep 4, 2026Sell(S)3K$358.42$1.1M1.3M
Sep 4, 2026Sell(S)3K$359.39$1.2M1.3M
Sep 4, 2026Sell(S)2K$360.47$836K1.3M
Sep 4, 2026Sell(S)1K$361.61$449K1.3M
Sep 4, 2026Sell(S)2K$362.65$722K1.3M
Sep 4, 2026Sell(S)565$363.34$205K1.3M
Sep 4, 2026Sell(S)1K$364.48$484K1.3M
Sep 4, 2026Sell(S)826$365.41$302K1.3M
Sep 4, 2026Sell(S)399$366.56$146K1.3M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001298711-26-000009) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about KRYS insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001298711-26-000009"
Ask your agent
Use Arkolith to summarize insider buying and selling at Krystal Biotech, Inc.
over the last 90 days and cite the filings.